U.S. Sen. Joe Manchin, D-W.Va., applauded the Food and Drug Administration’s (FDA) decision to strengthen training and prescribing practices for immediate release opioids by adding them to the FDA’s Risk Evaluation and Mitigation Strategy (REMS).